Compounding Overview: Primary Considerations for the Workplace.
In: Pharmaceutical Technology Europe, Jg. 36 (2024-02-01), Heft 2, S. 25-30
serialPeriodical
Zugriff:
The article focuses on pharmaceutical compounding, highlighting key considerations such as technical aspects, regulatory requirements, and personnel responsibilities. Topics discussed include formulation design, U.S. Food and Drug Administration (FDA) regulations for 503A and 503B compounding facilities, and the importance of personnel training and quality assurance in the compounding workplace.
Titel: |
Compounding Overview: Primary Considerations for the Workplace.
|
---|---|
Autor/in / Beteiligte Person: | Pluta, Paul L. |
Zeitschrift: | Pharmaceutical Technology Europe, Jg. 36 (2024-02-01), Heft 2, S. 25-30 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1753-7967 (print) |
Schlagwort: |
|
Sonstiges: |
|